Página principal > Resultados de la búsqueda: Armand, Philippe
  Consejos para la búsqueda
Búsqueda avanzada
Buscar colecciones:
Ordenar por: Mostrar resultados: Formato de visualización:
Resultados globales: 2 registros encontrados en 0.01 segundos.
Artículos, Encontrados 2 registros
Artículos Encontrados 2 registros  
1.
8 p, 894.2 KB Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma / Kekre, N. (The Ottawa Hospital) ; Marquez-Malaver, Francisco J. (Instituto de Biomedicina de Sevilla) ; Cabrero, Monica (Instituto Biosanitario de Salamanca (IBSAL)) ; Piñana, J. (Hospital Clínic Universitari (València)) ; Esquirol, Albert (Institut d'Investigació Biomèdica Sant Pau) ; Soiffer, Robert J. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Caballero, Dolores (Instituto Biosanitario de Salamanca (IBSAL)) ; Terol, M.J. (Hospital Clínic Universitari (València)) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Antin, Joseph H. (Harvard Medical School) ; Lopez-Corral, L. (Instituto Biosanitario de Salamanca (IBSAL)) ; Solano, Carlos (Hospital Clínic Universitari (València)) ; Armand, Philippe (Harvard Medical School) ; Pérez-Simon, Jose A. (Instituto de Biomedicina de Sevilla) ; Universitat Autònoma de Barcelona
There is at present little data to guide the choice of conditioning for patients with lymphoma undergoing reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (SCT). In this study, we compared the outcomes of patients undergoing RIC SCT who received fludarabine and melphalan (FluMel), the standard RIC regimen used by the Spanish Group of Transplantation, and fludarabine and busulfan (FluBu), the standard RIC regimen used by the Dana-Farber Cancer Institute/Brigham and Women's Hospital. [...]
2016 - 10.1016/j.bbmt.2016.07.006
Biology of blood and marrow transplantation, Vol. 22 Núm. 10 (january 2016) , p. 1808-1815  
Registro completo - Creative Commons
2.
34 p, 950.5 KB Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies / Pasquini, Marcelo (Medical College of Wisconsin) ; Zhang, Mei-Jie (Medical College of Wisconsin) ; Medeiros, Bruno (Stanford University School of Medicine) ; Armand, Philippe (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Hu, Zhen-Huan (Medical College of Wisconsin) ; Nishihori, Taiga (H. Lee Moffitt Cancer Center and Research Institute) ; Aljurf, Mahmoud D. (King Faisal Specialist Hospital Center and Research) ; Akpek, Görgün (Banner MD Anderson Cancer Center) ; Cahn, Jean-Yves (University Hospital) ; Cairo, Mitchell S. (New York Medical College) ; Cerny, Jan (UMass Memorial Medical Center) ; Copelan, Edward A. (Carolinas HealthCare System) ; Deol, Abhinav (Wayne State University) ; Freytes, César O. (University of Texas Health Science Center San Antonio) ; Gale, Robert Peter (Imperial College London) ; Ganguly, Siddhartha (University of Kansas Medical Center) ; George, Biju (Christian Medical College) ; Gupta, Vikas (University Health Network) ; Hale, Gregory A. (All Children's Hospital) ; Kamble, Rammurti T. (Baylor College of Medicine) ; Klumpp, Thomas R. (Thomas Jefferson University Hospital) ; Lazarus, Hillard M. (University Hospitals Case Medical Center) ; Luger, Selina M. (University of Pennsylvania Medical Center) ; Liesveld, Jane L. (University of Rochester Medical Center) ; Litzow, Mark Robert (Mayo Clinic) ; Marks, David I. (University Hospitals Bristol NHS Trust) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Norkin, Maxim (University of Florida College of Medicine) ; Olsson, Richard F. (Uppsala University) ; Oran, Betul (The University of Texas MD Anderson Cancer Center) ; Pawarode, Attaphol (University of Michigan) ; Pulsipher, Michael A. (University of Southern California Keck School of Medicine) ; Ramanathan, Muthalagu (UMass Memorial Medical Center) ; Reshef, Ran (University of Pennsylvania Medical Center) ; Saad, Ayman A. (University of Alabama at Birmingham) ; Saber, Wael (Medical College of Wisconsin) ; Savani, Bipin N. (Vanderbilt University Medical Center) ; Schouten, Harry C. (Academische Ziekenhuis) ; Ringdén, Olle (Centre for Allogeneic Stem Cell Transplantation) ; Tallman, Martin S. (Memorial Sloan Kettering Cancer Center) ; Uy, Geoffrey L. (Washington University School of Medicine) ; Wood, William A. (University of North Carolina) ; Wirk, Baldeep (Seattle Cancer Care Alliance) ; Pérez, Waleska S. (Medical College of Wisconsin) ; Batiwalla, Minoo (National Heart Lung and Blood Institute - National Institutes of Health) ; Weisdorf, Daniel J. (University of Minnesota Medical Center) ; Universitat Autònoma de Barcelona
The presence of monosomal karyotype (MK+) in acute myeloid leukemia (AML) is associated with dismal outcomes. We evaluated the impact of MK+ in AML (MK+AML, n = 240) and in myelodysplastic syndrome (MDS) (MK+MDS, n = 221) on hematopoietic cell transplantation outcomes compared with other cytogenetically defined groups (AML, n = 3360; MDS, n = 1373) as reported to the Center for International Blood and Marrow Transplant Research from 1998 to 2011. [...]
2016 - 10.1016/j.bbmt.2015.08.024
Biology of blood and marrow transplantation, Vol. 22 Núm. 2 (january 2016) , p. 248-257  
Registro completo - Creative Commons

Vea también: autores con nombres similares
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.
Depósito Digital de Documentos de la UAB :: Buscar :: Enviar :: Personalizar :: Ayuda
Powered by Invenio v1.1.6
Mantenido por ddd.bib@uab.cat  :: Metadatos sujetos a:
Colaboramos